Latest Pharma acquisation news Sep 23, 2020... Sep 23
Oxford Nanopore Technologies Sign Non-Exclusive Licensing Agreement for Genetics Research’s Patented DNA Negative Enrichment Technology Platform ... Sep 23
After Japan, EU approves AstraZeneca Imfinzi , along with chemotherapy it could treat small cell lung cancer... Sep 02
-Advertisements-